Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
150
days
Real-Life 1-Year Results and Predictors of Visual Outcome with Intravitreal Faricimab for Treatment of Exudative Neovascular Age-Related Macular Degeneration
AuthorsFederico Beretta; Giovanni Scalabrin; Edoardo Balduzzi; Stefano Puligheddu; Francesco Bandello; Riccardo Sacconi; Giuseppe Querques
Affiliations1. School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; 2. Division of Head and Neck, Ophthalmology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; 3. Department of Surgical, Medical, Dental and Morphological Sciences, Faculty of Medicine, University of Modena and Reggio Emilia (UNIMORE), Modena, Italy; 4. Ophthalmology Unit, Policlinic of Modena, Modena, Italy
29
days
Aflibercept 24-Month Outcomes in Diabetic Macular Edema With and Without Prior Macular Laser Therapy: Data from the Fight Retinal Blindness! Registry
AuthorsLuca Timoceanu; Sarah Steinmann; Mark C. Gillies; Daniel Barthelmes
Affiliations1. Department of Ophthalmology, University Hospital Zurich and University of Zurich, Zurich, Switzerland; 2. Save Sight Institute, The Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
136
days
Experiences and Perspectives on Diabetic Retinopathy Screening and Treatment in Mexico: A Subanalysis of the Diabetic Retinopathy Barometer Study
AuthorsIngrid Y. Pita-Ortiz; Raul Velez-Montoya; Marlon García Roa; Beatriz J. Pérez Aragón; Luis F. Rosales Rodríguez
Affiliations1. Retina and Vitreous Department, Fundación Hospital Nuestra Señora de la Luz, Mexico City, Mexico; 2. Retina Department, Asociación para Evitar la Ceguera en México, IAP, Mexico City, Mexico; 3. Retina Department, Instituto Mexicano de Oftalmologia IMO, Santiago de Querétaro, Mexico; 4. SalaUno salud S.A.P.I de C.V., Mexico City, Mexico; 5. Ophthalmology Department, Clínica Hospital ISSSTE Dr. Roberto Nettel Flores, Tapachula, Mexico
55
days
Identification of OCTA Biomarkers and Cutoff Values Associated with Disease Severity in Dry Age-Related Macular Degeneration
AuthorsBogdan Dugiełło; Katarzyna Bujała; Bartłomiej Bolek; Adam Wylęgała; Edward Wylęgała
Affiliations1. Chair and Clinical Department of Ophthalmology, School of Medicine in Zabrze, Medical University of Silesia in Katowice, District Railway Hospital, Katowice, Poland; 2. Experimental Ophthalmology Unit, Department of Biophysics, Silesian Medical University, Katowice, Poland
67
days
Intraoperative Modified Peripheral Panretinal Photocoagulation in Proliferative Diabetic Retinopathy
AuthorsXiang Gao; Shanshan Zhang; Liying Qin; Jingjing Zhang; Jingyi Tian; Xiaolei Sun; Gongqiang Yuan
Affiliations1. Eye Institute of Shandong First Medical University, Eye Hospital of Shandong First Medical University, Jinan, China; 2. State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Qingdao, China; 3. School of Ophthalmology, Shandong First Medical University, Jinan, China; 4. Qingdao Eighth People’s Hospital, Qingdao, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days